<DOC>
	<DOCNO>NCT02274480</DOCNO>
	<brief_summary>The goal study see special type heart scan call diffusion weight magnetic resonance imaging ( DW-MRI ) use extra measurement , use find early sign heart damage chemotherapy .</brief_summary>
	<brief_title>Diffusion Weighted Imaging Biomarker Detection Chemotherapy Induced Cardiotoxicity</brief_title>
	<detailed_description>This prospective single institutional pilot study enroll breast cancer patient develop cardiotoxicity anthracycline anti-HER2 therapy . The control group compose patient similar anthracycline therapy dose without decline LVEF Cardiac MRI ( CMR ) . Clinic visit monitor cardiotoxicity occur part standard care therapy initiation . The study control group compose 15 patient . At discretion treat physician , patient recruit Breast Medical Oncology Service .</detailed_description>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Cardiotoxicity</mesh_term>
	<criteria>≥18 year age day sign informed consent . Diagnosis HER2+ breast cancer History anthracycline therapy antiHER2 treatment For subject decrease LVEF : Recent ( within 12 week ) drop LVEF ≥10 % echocardiogram baseline confirm cardiac MRI study population . If drop EF confirm MRI , subject remove placed control group . For control group : Less 10 % change EF baseline control population confirm echocardiogram cardiac MRI . If change EF confirm MRI , subject remove placed study group change EF equal great 10 % . Note : Male breast cancer patient uncommon expect include study , however meet criterion , exclude . Prior myocardial infarction Prior surgical percutaneous coronary revascularization Pregnant lactating patient Patients general medical psychiatric condition , physiologic status unrelated presence breast cancer give valid inform consent Patients unwilling unable undergo MRI include patient contraindication MRI presence cardiac pacemaker noncompatible intracranial vascular clip , claustrophobia , inability lie flat duration study etc . MRI eligibility determine day consent MRI questionnaire . Patients metallic implant device chest might distort local magnetic field compromise quality MRI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>MRI</keyword>
	<keyword>Diffusion Weighted Imaging</keyword>
	<keyword>14-191</keyword>
</DOC>